Revvity | PKI - Vertriebs- Und Verwaltungskosten





Vertriebs- Und Verwaltungskosten Veränderung Datum
Agilent USD 465M 11M 2026-03
Align Technology USD 462.67M 2.67M 2026-06
Bio Techne USD 109.34M 4.35M 2026-03
Bio-Rad Laboratories USD 212M 400K 2026-06
Bruker USD 238.9M 3.2M 2026-06
Celltrion KRW 9.32B 3.39B 2026-03
Charles River Laboratories USD 228.9M 69.47M 2026-06
Cspc Pharmaceutical CNY 1.87B 95.62M 2025-12
Danaher USD 2.07B 212M 2026-06
Dentsply International USD 351M 32M 2026-03
Deva Holding AS TRY 462.26M 48.18M 2023-09
Dianthus Therapeutics USD 12.47M 5.89M 2026-03
Divis Laboratories Ltd INR 3.4B 10M 2025-06
Edwards Lifesciences USD 561.2M 39M 2026-06
Illumina USD 273M 1000K 2026-06
Intuitive Surgical USD 617.9M 4.6M 2026-06
IQVIA Holdings USD 574M 72M 2026-06
Kangmei Pharma CNY 237.06M 37.35M 2026-03
Knight Therapeutics CAD 35.45M 4.43M 2025-12
Laboratorios Farma EUR 35.32M 2.75M 2025-06
Laboratory Of America USD 577.2M 26.2M 2026-06
Malin Corporation EUR 1.1M 400K 2024-12
Medical Developments International AUD 2.84M 4.19M 2025-12
Mesa Laboratories USD 27.31M 380K 2024-09
Mettler Toledo International USD 263.33M 5.01M 2026-06
Myriad Genetics USD 122.3M 6.7M 2025-12
Neuren Pharmaceuticals AUD 3.74M 2.5M 2025-12
OraSure Technologies USD 13.21M 3.29M 2025-12
Organigram Holdings CAD 22.01M 14.28M 2026-03
Ovoca Bio EUR 617K 15K 2025-12
Pacific Biosciences Of California USD 37.24M 25.68M 2025-12
Pharma Mar EUR 17.12M 1.82M 2026-06
Qiagen NV USD 142.39M 11.49M 2026-03
Quest Diagnostics USD 529M 25M 2026-06
Quidel USD 199.3M 4.9M 2026-03
Repligen USD 76.62M 82K 2026-06
Revvity USD 278.58M 24.69M 2026-06
Sartorius EUR 221.3M 0 2026-06
Sino Biopharmaceutical CNY 7.54B 2.23B 2025-06
Thermo Fisher Scientific USD 1.91B 111M 2026-06
Tilray USD 24.85M 1.7M 2025-09
Waters USD 405M 11M 2026-06
Zealand Pharma A/S 104M 12.19M 2026-03
Zz Pientze Pharmaceu CNY 214.31M 42.4M 2026-03